Table 1. Details of demographic and clinicopathological parameters of oral squamous cell carcinoma patients.
| Characteristics | OSCC (n = 217) | |
|---|---|---|
| Age | Mean (SD) | 50.25 (±12.14) |
| Range | 20 - 79 | |
| Gender | Male | 159 (73.27%) |
| Female | 35 (26.72%) | |
| Site | Buccal Mucosa | 84 (38.70%) |
| Gingivo-buccal Sulcus | 69 (31.79%) | |
| Tongue | 24 (11.05%) | |
| Retromaolar | 16 (7.37%) | |
| Palate | 10 (4.60%) | |
| Labial Mucosa | 11 (5.06%) | |
| Floor of Mouth | 3 (1.38%) | |
| Histopathological diagnosis | WDSCC | 100 (46.08%) |
| MDSCC | 106 (48.84%) | |
| PDSCC | 11 (5.06%) | |
| Habits | Tobacco and lime | 45 (20.73%) |
| Tobacco lime and Betel nut | 135 (62.21%) | |
| Betel nut | 33 (15.20%) | |
| No habits | 4 (1.84%) | |
| Clinical TNM Stage | Stage I | 16 (7.37%) |
| Stage II | 52 (23.96%) | |
| Stage III | 55 (25.34%) | |
| Stage IV | 94 (43.31%) | |
| Clinical TNM Stage | Early Stage | 68 (31.33%) |
| Advanced Stage | 149 (68.66%) | |
| Metastasis | Non-meta | 141 (64.97%) |
| Metastatic | 76 (35.02%) | |
| 3 years disease free survival (n=217) | Non-survived | 69 (31.79%) |
| Survived | 148 (68.20%) | |
| 5 years disease free survival (n=150) | Non-survived | 69 (46.00%) |
| Survived | 81 (54.00%) | |
Note:- OSCC: Oral squamous cell carcinoma, WDSCC: Well differentiated squamous cell carcinoma, MDSCC: Moderately differentiated squamous cell carcinoma, PDSCC: Poorly differentiated squamous cell carcinoma, SD: standard deviation, TNM: Tumor (T) Nodes (N) and Metastasis (M).